• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RP-UHPLC-DAD-MS用于薄膜包衣片中索磷布韦定性和定量分析及降解产物剖析的潜力

Potential of RP-UHPLC-DAD-MS for the qualitative and quantitative analysis of sofosbuvir in film coated tablets and profiling degradants.

作者信息

Contreras María Del Mar, Morales-Soto Aránzazu, Segura-Carretero Antonio, Valverde Javier

机构信息

Department of Analytical Chemistry, Faculty of Sciences, University of Granada, Avenida Fuentenueva s/n, 18071 Granada, Spain.

Research and Development Functional Food Centre (CIDAF), Bioregión Building, Health Science Technological Park, Avda. Del Conocimiento s/n, 18016 Granada, Spain.

出版信息

J Pharm Anal. 2017 Aug;7(4):208-213. doi: 10.1016/j.jpha.2017.04.003. Epub 2017 Apr 14.

DOI:10.1016/j.jpha.2017.04.003
PMID:29404040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5790698/
Abstract

Sofosbuvir is one of the new direct-acting antiviral drugs against hepatitis C virus (HCV) infection. This drug has recently been launched into the market, and generic versions of the medication are expected to be produced by local drug producers in some countries. Therefore, new methods are required to control sofosbuvir in pharmaceuticals. In the present study, a new method based on reversed phase (RP)-ultra-high performance liquid chromatography (UHPLC) coupled to diode array detection (DAD) and mass spectrometry (MS) was developed to facilitate the qualitative and quantitative analysis of sofosbuvir in film coated tablets. A wavelength of 260 nm was selected to perform a cost-effective quantification and the method showed adequate linearity, with an value of 0.9998, and acceptable values of accuracy (75%-102%) and precision (residual standard deviation <5%). The detection and quantification limits were 0.07 μg/mL and 0.36 μg/mL, respectively. Furthermore, the use of high-resolution MS enabled us to ensure the specificity, check impurities and better sensitivity. Therefore, this methodology promises to be suitable not only for the routine analysis of sofosbuvir in pharmaceutical dosage forms, but also for potential degradants.

摘要

索磷布韦是一种新型的抗丙型肝炎病毒(HCV)感染的直接作用抗病毒药物。该药物最近已投放市场,预计一些国家的当地药品生产商将生产其仿制药。因此,需要新的方法来控制药品中的索磷布韦。在本研究中,开发了一种基于反相(RP)-超高效液相色谱(UHPLC)结合二极管阵列检测(DAD)和质谱(MS)的新方法,以促进对薄膜包衣片中索磷布韦的定性和定量分析。选择260nm波长进行经济高效的定量分析,该方法显示出足够的线性,r值为0.9998,准确度(75%-102%)和精密度(剩余标准偏差<5%)值均可接受。检测限和定量限分别为0.07μg/mL和0.36μg/mL。此外,使用高分辨率质谱使我们能够确保特异性、检查杂质并提高灵敏度。因此,该方法不仅有望适用于药物剂型中索磷布韦的常规分析,也适用于潜在的降解产物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/e8500ca3e894/mmc2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/99cff17d1e66/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/564a22d7280c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/925f820ee617/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/b0a39e373b38/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/b1b0635b9c1c/mmc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/e8500ca3e894/mmc2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/99cff17d1e66/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/564a22d7280c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/925f820ee617/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/b0a39e373b38/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/b1b0635b9c1c/mmc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a04/5790698/e8500ca3e894/mmc2.jpg

相似文献

1
Potential of RP-UHPLC-DAD-MS for the qualitative and quantitative analysis of sofosbuvir in film coated tablets and profiling degradants.RP-UHPLC-DAD-MS用于薄膜包衣片中索磷布韦定性和定量分析及降解产物剖析的潜力
J Pharm Anal. 2017 Aug;7(4):208-213. doi: 10.1016/j.jpha.2017.04.003. Epub 2017 Apr 14.
2
Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies.建立并验证了一种高效液相色谱-二极管阵列检测法(HPLC-DAD),用于在存在七种潜在杂质的情况下同时测定抗病毒药物达卡他韦、来迪派韦、索非布韦和利巴韦林。该方法用于制剂的测定和溶出度研究。
Drug Dev Ind Pharm. 2019 Jul;45(7):1111-1119. doi: 10.1080/03639045.2019.1593444. Epub 2019 Apr 1.
3
Development and validation of a new HPLC-DAD method for quantification of sofosbuvir in human serum and its comparison with LC-MS/MS technique: Application to a bioequivalence study.一种用于定量测定人血清中索磷布韦的新型高效液相色谱-二极管阵列检测法(HPLC-DAD)的开发与验证及其与液相色谱-串联质谱法(LC-MS/MS)技术的比较:在生物等效性研究中的应用
J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Sep 15;1063:118-122. doi: 10.1016/j.jchromb.2017.06.047. Epub 2017 Aug 31.
4
HPLC-UV and TLC-Densitometry Methods for Simultaneous Determination of Sofosbuvir and Daclatasvir: Application to Darvoni® Tablet.HPLC-UV 和 TLC-Densitometry 法同时测定索非布韦和达卡他韦:应用于 Darvoni®片剂。
J Chromatogr Sci. 2022 Jul 12;60(6):606-612. doi: 10.1093/chromsci/bmab100.
5
UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.用于同时定量检测HIV/HCV合并感染患者血浆中索磷布韦、索磷布韦代谢物(GS-331007)和达卡他韦的超高效液相色谱-串联质谱法。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 15;1073:183-190. doi: 10.1016/j.jchromb.2017.12.018. Epub 2017 Dec 12.
6
Forced degradation and impurity profiling: recent trends in analytical perspectives.强制降解和杂质剖析:分析视角的最新趋势。
J Pharm Biomed Anal. 2013 Dec;86:11-35. doi: 10.1016/j.jpba.2013.07.013. Epub 2013 Jul 31.
7
Rapid and sensitive UHPLC-DAD method for simultaneous determination of sofosbuvir and ledipasvir in human serum.快速灵敏的 UHPLC-DAD 法同时测定人血清中索非布韦和来迪派韦。
J Pharm Biomed Anal. 2021 Feb 20;195:113860. doi: 10.1016/j.jpba.2020.113860. Epub 2020 Dec 22.
8
Chemometrically Assisted Development of Ultra-High-Performance Liquid Chromatography Method for the Simultaneous Quantification of Sofosbuvir, Daclatasvir and Ledipasvir in Pharmaceutical Dosage Forms.化学计量学辅助开发超高效液相色谱法同时测定药物剂型中索磷布韦、达卡他韦和来迪帕司韦的含量
J Chromatogr Sci. 2020 Jan 17;57(10):910-919. doi: 10.1093/chromsci/bmz076.
9
[Evaluation of drug-drug interactions between yimitasvir phosphate capsules with sofosbuvir tablets, omeprazole magnesium enteric-coated tablets, and rosuvastatin calcium tablets].[磷酸依米他韦胶囊与索磷布韦片、奥美拉唑镁肠溶片和瑞舒伐他汀钙片之间的药物相互作用评价]
Zhonghua Gan Zang Bing Za Zhi. 2020 Oct 20;28(10):838-843. doi: 10.3760/cma.j.cn501113-20200907-00503.
10
Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms.一种经验证的反相高效液相色谱梯度洗脱法,用于同时测定抗病毒药物:索非布韦、来迪派韦、达卡他韦和西美瑞韦在其制剂中的含量。
Molecules. 2020 Oct 10;25(20):4611. doi: 10.3390/molecules25204611.

引用本文的文献

1
In Vitro, In Silico, and In Vivo Studies of Linn as a Potential Antidiabetic Agent in a Rat Model.辣木作为大鼠模型中潜在抗糖尿病药物的体外、计算机模拟和体内研究
ACS Omega. 2023 Jun 12;8(25):22623-22636. doi: 10.1021/acsomega.3c01034. eCollection 2023 Jun 27.
2
Development of a Methodology for Estimating the Ergosterol in Meat Product-Borne Toxigenic Moulds to Evaluate Antifungal Agents.开发一种用于估计肉制品中产毒霉菌麦角甾醇以评估抗真菌剂的方法。
Foods. 2021 Feb 17;10(2):438. doi: 10.3390/foods10020438.

本文引用的文献

1
Access to new direct-acting antiviral agents against HCV infection: A view from Spain.获得针对丙型肝炎病毒感染的新型直接抗病毒药物:西班牙的视角。
Clin Liver Dis (Hoboken). 2015 Mar 4;5(1):22-23. doi: 10.1002/cld.444. eCollection 2015 Jan.
2
Stability-Indicating Method and LC-MS-MS Characterization of Forced Degradation Products of Sofosbuvir.索磷布韦强制降解产物的稳定性指示方法及液相色谱-串联质谱表征
J Chromatogr Sci. 2016 Oct 17;54(9):1631-1640. doi: 10.1093/chromsci/bmw119.
3
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma.
开发一种用于测定人血浆中丙型肝炎病毒抑制剂西米普明的简单高效液相色谱-紫外检测法。
J Pharm Biomed Anal. 2016 Mar 20;121:197-203. doi: 10.1016/j.jpba.2016.01.019. Epub 2016 Jan 13.
4
Characterization of forced degradation products and in silico toxicity prediction of Sofosbuvir: A novel HCV NS5B polymerase inhibitor.索磷布韦的强制降解产物表征及计算机辅助毒性预测:一种新型丙型肝炎病毒NS5B聚合酶抑制剂
J Pharm Biomed Anal. 2016 Feb 20;120:352-63. doi: 10.1016/j.jpba.2015.12.045. Epub 2015 Dec 29.
5
Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS.通过超高效液相色谱-串联质谱法同时定量大鼠血浆中利巴韦林、索磷布韦及其代谢物的快速方法的评估。
J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Oct 1;1002:353-7. doi: 10.1016/j.jchromb.2015.08.038. Epub 2015 Aug 30.
6
Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study.开发一种灵敏的超高效液相色谱-电喷雾串联质谱法用于定量测定人血浆中的索磷布韦及其代谢产物GS-331007:在生物等效性研究中的应用
J Pharm Biomed Anal. 2015 Oct 10;114:97-104. doi: 10.1016/j.jpba.2015.05.006. Epub 2015 May 18.
7
Improved high sensitivity analysis of polyphenols and their metabolites by nano-liquid chromatography-mass spectrometry.纳米液相色谱-质谱法提高多酚及其代谢物的高灵敏度分析。
Arch Biochem Biophys. 2014 Oct 1;559:3-11. doi: 10.1016/j.abb.2014.06.014. Epub 2014 Jun 23.
8
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.来迪派韦索磷布韦片与索磷布韦联用治疗初治的 HCV 基因 1 型感染。
N Engl J Med. 2014 May 15;370(20):1889-98. doi: 10.1056/NEJMoa1402454. Epub 2014 Apr 11.
9
A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir.一种针对丙型肝炎病毒的新型有前途的治疗选择:口服核苷酸 NS5B 聚合酶抑制剂索非布韦。
Curr Med Chem. 2013;20(30):3733-42. doi: 10.2174/09298673113209990178.
10
Multiplex liquid chromatography-tandem mass spectrometry assay for simultaneous therapeutic drug monitoring of ribavirin, boceprevir, and telaprevir.多重液相色谱-串联质谱法同时测定利巴韦林、博赛泼维及特拉匹韦的治疗药物浓度。
Antimicrob Agents Chemother. 2013 Jul;57(7):3147-58. doi: 10.1128/AAC.00281-13. Epub 2013 Apr 29.